Nuveen’s Guardian Pharmacy Services GRDN Stock Holding History

Nuveen’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.24M	Sell	220,791 -316,660	-59%	-$12.3M	﹤0.01%	1741
2026 Q1	$20.2M	Sell	537,451 -104,917	-16%	-$3.43M	0.01%	1136
2025 Q4	$19.3M	Buy	642,368 +76,025	+13%	+$2.15M	0.01%	1160
2025 Q3	$14.9M	Buy	566,343 +14,449	+3%	+$344K	﹤0.01%	1324
2025 Q2	$11.8M	Sell	551,894 -500,520	-48%	-$11.3M	﹤0.01%	1411
2025 Q1	$33.3M	Buy	1,052,414 +505,274	+92%	+$10.4M	0.01%	819
2024 Q4	$11.1M	Buy	547,140 +15,550	+3%	+$321K	﹤0.01%	1541
2024 Q3	$8.93M	Buy	+531,590	New	+$8.96M	﹤0.01%	1680

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Nuveen's GRDN Position: Q2 2026 in Review

Nuveen reduced its Guardian Pharmacy Services (GRDN) stake by 59% in Q2 2026, selling an estimated $12.3M and leaving 220,791 shares worth $9.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1741.

Nuveen first reported a position in GRDN in Q3 2024 and has held it in 8 quarters since. The position peaked at $33.3M in Q1 2025. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

Nuveen held 220,791 shares of Guardian Pharmacy Services worth $9.24M as of Q2 2026.
Nuveen sold 316,660 Guardian Pharmacy Services shares in Q2 2026, an estimated $12.3M.
Guardian Pharmacy Services made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1741 holding.
Nuveen first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 8 quarters since.
Nuveen's Guardian Pharmacy Services position peaked at $33.3M in Q1 2025.
190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.